首页> 外文学位 >The Roles of Akt1 and Akt2 Downstream of Src Family Kinases in the Migration and Invasion of Breast Cancer Cells.
【24h】

The Roles of Akt1 and Akt2 Downstream of Src Family Kinases in the Migration and Invasion of Breast Cancer Cells.

机译:Src家族激酶下游的Akt1和Akt2在乳腺癌细胞迁移和侵袭中的作用。

获取原文
获取原文并翻译 | 示例

摘要

The leading cause of death in breast cancer patients is metastasis. Cancer metastasis involves a complex series of events, including cell detachment from the primary tumor, invasion into the surrounding tissue, intravasation into the circulatory system, extravasation, and growth in a new organ. Src Family Kinases (SFKs) comprise a group of non-receptor tyrosine kinases that regulate a variety of pathways that promote cell survival, growth, proliferation, motility, and invasion. Previous studies have found a correlation between the activity of SFKs and the progression of breast cancer into metastasis. Since the pathways regulated by SFKs are often activated in metastasis, I investigated whether SFKs play a role in the metastasis of breast cancer cells.;To determine whether SFKs regulate breast cancer metastasis, I analyzed the role of SFKs in the migration and invasion of a metastatic breast cancer cell line, MDA-MB-231 cells. SFKs were inhibited with expression of dominant negative Src or by treatment with the pharmacological inhibitors PP2 and SU6656. The inhibition of SFKs in MDA-MB-231 cells led to decreased cell migration and invasion through transwell migration and invasion chambers. To explore the mechanism by which SFKs regulate cellular migration and invasion, I investigated whether SFKs regulate the Akt1 and Akt2 isoforms in MDA-MB-231 breast cancer cells. Akt isoforms are serine/threonine kinases that are often activated in cancer cells. The activity of Akt isoforms were decreased in SFK-inhibited MDA-MB-231 cells as determined by immunoblot detection of the phosphorylation of Threonine 308 and Serine 473 residues, in vitro kinase assays, and immunoblot detection of the phosphorylation of an Akt substrate. To determine whether the Akt isoforms play a role in the migration and/or invasion of breast cancer cells, small interfering RNAs were used to knockdown the expression of each Akt isoform. Akt2 knockdown specifically led to decreased MDA-MB-231 cell migration and invasion by mechanisms that did not involve the attachment of cells onto extracellular matrix or the regulation of Pak1. Co-immunoprecipitation and mass spectrometry assays were used in an effort to identify an Akt2-specific binding partner that could mediate its role in breast cancer cell migration and invasion. The Arf6-GAP ACAP2 was identified as a protein that co-immunoprecipitated with Akt2-Flag, but additional analysis found that ACAP2 was immunoprecipitated non-specifically by the mouse anti-Flag antibody and does not interact with Akt2.;These results point to a role of SFKs in breast cancer metastasis, specifically in promoting cell migration and invasion. Although SFKs regulate the activation of both Akt1 and Akt2 isoforms in MDA-MB-231 cells, only Akt2 is required for the migration and invasion of MDA-MB-231 cells.
机译:乳腺癌患者的主要死亡原因是转移。癌症转移涉及一系列复杂的事件,包括细胞从原发肿瘤中脱离,侵入周围组织,向循环系统内的浸润,外渗以及新器官的生长。 Src家族激酶(SFK)包含一组非受体酪氨酸激酶,可调节多种促进细胞存活,生长,增殖,运动和侵袭的途径。先前的研究已经发现SFK的活性与乳腺癌向转移的进展之间存在相关性。由于SFK调节的通路通常在转移中被激活,因此我研究了SFK是否在乳腺癌细胞的转移中起作用;为了确定SFK是否调节乳腺癌的转移,我分析了SFK在癌的迁移和侵袭中的作用。转移性乳腺癌细胞系MDA-MB-231细胞。通过显性阴性Src的表达或通过药理抑制剂PP2和SU6656的治疗可抑制SFK。 MDA-MB-231细胞中SFK的抑制作用导致细胞通过跨孔迁移和侵袭室的迁移和侵袭减少。为了探索SFK调节细胞迁移和侵袭的机制,我研究了SFK是否调节MDA-MB-231乳腺癌细胞中的Akt1和Akt2亚型。 Akt亚型是丝氨酸/苏氨酸激酶,通常在癌细胞中被激活。通过对苏氨酸308和丝氨酸473残基的磷酸化进行免疫印迹检测,体外激酶测定以及对Akt底物的磷酸化进行免疫印迹检测,可确定SFK抑制的MDA-MB-231细胞中Akt异构体的活性降低。为了确定Akt同工型是否在乳腺癌细胞的迁移和/或侵袭中起作用,使用小的干扰RNA敲低每种Akt同工型的表达。通过不涉及细胞附着于细胞外基质或Pak1调控的机制,Akt2敲低可特异性降低MDA-MB-231细胞的迁移和侵袭。使用免疫共沉淀和质谱分析法来鉴定可以介导其在乳腺癌细胞迁移和侵袭中作用的Akt2特异性结合伴侣。 Arf6-GAP ACAP2被鉴定为与Akt2-Flag共免疫沉淀的蛋白,但进一步的分析发现ACAP2被小鼠抗Flag抗体非特异性免疫沉淀并且不与Akt2相互作用;这些结果表明SFK在乳腺癌转移中的作用,特别是在促进细胞迁移和侵袭中的作用。尽管SFK可以调节MDA-MB-231细胞中Akt1和Akt2同种型的激活,但MDA-MB-231细胞的迁移和侵袭只需要Akt2。

著录项

  • 作者

    Chiueh, Venice Calinisan.;

  • 作者单位

    University of California, Berkeley.;

  • 授予单位 University of California, Berkeley.;
  • 学科 Biology Molecular.;Health Sciences Oncology.;Biology Cell.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 83 p.
  • 总页数 83
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号